Compounds > etravirine
Page last updated: 2024-09-05

etravirine and Co-infection

etravirine has been researched along with Co-infection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldamiz-Echevarria, T; Barros, C; Condés, E; de Cea, AM; González-Garcia, J; Moreno, A; Moreno, JS; Pérez-Elías, MJ; Quereda, C; Ramirez, ML; Santos, I; Torralba, M; Vargas, FX1
Baccarani, U; Bassetti, M; Bonora, S; Dal Zoppo, S; Della Siega, P; Delle Foglie, P; Giglio, O; Londero, A; Nasta, P; Pea, F; Righi, E; Villa, G1
Bañón, S; Casado, JL; Castro, A; Mena, A; Moreno, A; Moreno, S; Pedreira, J; Quereda, C1
Burger, DM; D'Avolio, A; Di Perri, G; Drenth, JP; Grintjes, K; Kanter, CT; Smolders, EJ; van Crevel, R1

Other Studies

4 other study(ies) available for etravirine and Co-infection

ArticleYear
Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.
    AIDS (London, England), 2014, Oct-23, Volume: 28, Issue:16

    Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Nitriles; Oligopeptides; Pyridazines; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome

2014
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: a report of three cases.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:1

    Topics: Anti-Retroviral Agents; Coinfection; Cyclohexanes; Darunavir; Drug Monitoring; Female; Hepatitis C; HIV Infections; Humans; Liver Cirrhosis; Liver Transplantation; Male; Maraviroc; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Triazoles

2015
Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
    HIV medicine, 2016, Volume: 17, Issue:1

    Topics: Adult; Aged; Alanine Transaminase; Anti-Retroviral Agents; Aspartate Aminotransferases; Coinfection; Female; Hepatitis C; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Nitriles; Prospective Studies; Pyridazines; Pyrimidines; Treatment Outcome

2016
Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir.
    AIDS (London, England), 2016, 06-01, Volume: 30, Issue:9

    Topics: Anti-HIV Agents; Antiviral Agents; Area Under Curve; Carbamates; Coinfection; Darunavir; Diuretics; Drug Interactions; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Pyrrolidines; Renal Insufficiency; Ritonavir; Treatment Outcome; Valine

2016